REMY BIOSCIENCES BIODERMAL TECHNOLOGY Trademark

Trademark Overview


On Thursday, September 22, 2022, a trademark application was filed for REMY BIOSCIENCES BIODERMAL TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the REMY BIOSCIENCES BIODERMAL TECHNOLOGY trademark a serial number of 97603139. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Wednesday, September 25, 2024. This trademark is owned by REMY Biosciences, Inc.. The REMY BIOSCIENCES BIODERMAL TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions
remy biosciences biodermal technology

General Information


Serial Number97603139
Word MarkREMY BIOSCIENCES BIODERMAL TECHNOLOGY
Filing DateThursday, September 22, 2022
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Description of MarkThe mark consists of The design mark consists of a six sided cube with only 3 sides visible. The cube consists of equally spaced blue dots having a double row of larger bolded dots located on both the left and right of the cube sides. The literal element consists of the words - remy biosciences biodermal technology - in blue and only having non capital letters and a larger bolded font for the word remy.
Goods and ServicesMedicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
NOT AVAILABLE"BIOSCIENCES" AND "TECHNOLOGY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREMY Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Coast, CA 92657

Party NameREMY Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Coast, CA 92657

Trademark Events


Event DateEvent Description
Monday, September 26, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 12, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 7, 2023ASSIGNED TO EXAMINER
Tuesday, June 20, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 20, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 20, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, September 20, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2024NON-FINAL ACTION WRITTEN
Monday, January 22, 2024NON-FINAL ACTION E-MAILED
Monday, January 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 25, 2024EXTENSION OF TIME TO OPPOSE RECEIVED